Fluvastatin
mRNA synthesis
In vitro transcription of capped mRNA with modified nucleotides and Poly(A) tail
Tyramide Signal Amplification (TSA)
TSA (Tyramide Signal Amplification), used for signal amplification of ISH, IHC and IC etc.
Phos Binding Reagent Acrylamide
Separation of phosphorylated and non-phosphorylated proteins without phospho-specific antibody
Cell Counting Kit-8 (CCK-8)
A convenient and sensitive way for cell proliferation assay and cytotoxicity assay
SYBR Safe DNA Gel Stain
Safe and sensitive stain for visualization of DNA or RNA in agarose or acrylamide gels.
Inhibitor Cocktails
Protect the integrity of proteins from multiple proteases and phosphatases for different applications.
Physical Appearance | A solid |
Storage | Store at -20°C |
M.Wt | 411.47 |
Cas No. | 93957-54-1 |
Formula | C24H26FNO4 |
Synonyms | Leschol |
Solubility | ≥20.57 mg/mL in DMSO; ≥32.53 mg/mL in H2O with gentle warming; ≥42.2 mg/mL in EtOH with gentle warming |
Chemical Name | (E,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid |
SDF | Download SDF |
Canonical SMILES | CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F |
运输条件 | 蓝冰运输或根据您的需求运输。 |
一般建议 | 不同厂家不同批次产品溶解度各有差异,仅做参考。若实验所需浓度过大至产品溶解极限,请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存,请尽快用完。 |
细胞实验 [1-3]: | |
细胞系 |
人类平滑肌细胞,人单核细胞U937细胞系 |
溶解方法 |
该化合物在DMSO中的溶解度大于20.6 mg/mL。若获取更高浓度的溶液,可在37℃下孵育10分钟,随后在超声波浴中摇匀。-20℃以下可储存数月。 |
反应条件 |
40 mg,6天 |
应用 |
在人类平滑肌细胞中,加入fluvastatin治疗的患者血清(一天40 mg氟伐他汀,6天)显著降低细胞增殖。Fluvastatin(100 nM)减弱ICAM-1和LFA-1表达。Fluvastatin(10 μM)对细胞活力无影响。Fluvastatin以时间和剂量依赖的方式诱导心肌细胞凋亡。Fluvastatin降低膜部分的RhoA蛋白,而细胞质部分中RhoA蛋白没有显著变化。Fluvastatin完全抑制白细胞介素-1β刺激的3H-亮氨酸掺入。 |
动物实验 [4-6]: | |
动物模型 |
Sprague–Dawley雄性大鼠 |
给药剂量 |
口服,5、10和20 mg/kg |
应用 |
在高胆固醇血症大鼠中,Fluvastatin (10 mg/kg/day)治疗显著减弱了对PAF和LTB4应答的白细胞粘附反应以及响应于LTB4的白细胞迁移反应。Fluvastatin抑制PAF和LTB4诱导的白细胞滚动速度的降低。口服Fluvastatin(5、10和20 mg/kg)显著抑制异丙肾上腺素诱导的心力衰竭和心肌损伤的几乎所有参数。与对照组比较,单独使用Fluvastatin(20 mg/kg)治疗的假手术大鼠的任何指标均未改变。Fluvastatin显著减少尿蛋白排泄。Fluvastatin显著改善了PAN肾病大鼠中肾素表达的降低。在存在中度蛋白尿的情况下,Fluvastatin显著减弱肾小管间质损伤。 |
注意事项 |
由于实验环境的不同,实际溶解度可能与理论值略有不同,请测试室内所有化合物的溶解度。 |
References: [1]. Buemi M, Allegra A, Senatore M, et al. Pro-apoptotic effect of fluvastatin on human smooth muscle cells[J]. European journal of pharmacology, 1999, 370(2): 201-203. [2]. Niwa S, Totsuka T, Hayashi S. Inhibitory effect of fluvastatin, an HMG-CoA reductase inhibitor, on the expression of adhesion molecules on human monocyte cell line[J]. International journal of immunopharmacology, 1996, 18(11): 669-675. [3]. Ogata Y, Takahashi M, Takeuchi K, et al. Fluvastatin induces apoptosis in rat neonatal cardiac myocytes: a possible mechanism of statin-attenuated cardiac hypertrophy[J]. Journal of cardiovascular pharmacology, 2002, 40(6): 907-915. [4]. Zhou R, Xu Q, Zheng P, et al. Cardioprotective effect of fluvastatin on isoproterenol-induced myocardial infarction in rat[J]. European journal of pharmacology, 2008, 586(1): 244-250. [5]. Kimura M, Kurose I, Russell J, et al. Effects of fluvastatin on leukocyte–endothelial cell adhesion in hypercholesterolemic rats[J]. Arteriosclerosis, Thrombosis, and Vascular Biology, 1997, 17(8): 1521-1526. [6]. Shibata S, Nagase M, Fujita T. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling[J]. Journal of the American Society of Nephrology, 2006, 17(3): 754-764. |
质量控制和MSDS
- 批次: